When to Choose Paroxetine Treatment in Skin-Picking Disorder: A Case Report

Abstract

Skin picking disorder (SPD) characterized by repetitive compulsive scratching in the absence of a primary skin disease is strongly associated with psychiatric comorbidities, including obsessive-compulsive disorder (OCD) and depression (MDD). Selective serotonin reuptake inhibitors (SSRIs) have been used in the treatment of SPD with variable success. Nevertheless, the optimum treatment choice for SPD is an issue for clinicians. This case report presents a 32-year-old female SPD patient treated with four-week paroxetine monotherapy. Based upon the clinical interview and standardized questionnaires, the patient was diagnosed with OCD with depressive features and Skin Picking Disorder. In addition to symptom severity scales, quantitative electroencephalography (qEEG) was also applied. Paroxetine treatment was started (titrated from 5 to 40 mg/day) and doubled each week. After four-week paroxetine monotherapy, OCD symptoms were diminished, and skin lesions were completely regressed leaving solely post inflammatory hyperpigmentation. Post-treatment qEEG assessment also showed a normalization of frontal alpha power and amplitude asymmetry. It can be concluded that if OCD includes SPD with abnormal EEG patterns; then the treatment success using paroxetine will be very high.

Keywords

alpha oscillations neurotic excoriation obsessive-compulsive disorder paroxetine QEEG skin-picking disorder

Get full access to this article

View all access options for this article.

References

Jafferany

Patel

. Skin-picking disorder: a guide to diagnosis and management. CNS Drugs. 2019;33(4):337–346. doi:10.1007/s40263-019-00621-7

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association;2013. doi:10.1176/appi.books.9780890425596

Brodin

. Neurotic excoriations. J Am Acad Dermatol. 2010;63(2):341–342. doi:10.1016/j.jaad.2009.11.592

Mutasim

Adams

. The psychiatric profile of patients with psychogenic excoriation. J Am Acad Dermatol. 2009;61(4):611–613. doi:10.1016/j.jaad.2009.03.038

Dell’Osso

Altamura

Mundo

Marazziti

Hollander

. Diagnosis and treatment of obsessive-compulsive disorder and related disorders. Int J Clin Pract. 2007;61(1):98–104. doi:10.1111/j.1742-1241.2006.01167.x

Schumer

Bartley

Bloch

. Systematic review of pharmacological and behavioral treatments for skin picking disorder. J Clin Psychopharmacol. 2016;36(2):147–152. doi:10.1097/JCP.0000000000000462

Saxena

Brody

, et al. Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder versus Major depression. Arch Gen Psychiatry. 2002;59(3):250. doi:10.1001/archpsyc.59.3.250

Goodman

Price

Rasmussen

, et al. The yale-brown obsessive compulsive scale: i. Development, use, and reliability. Arch Gen Psychiatry. 1989;46(11):1006–1011. doi:10.1001/archpsyc.1989.01810110048007

Hamilton

. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56–62. doi:10.1136/jnnp.23.1.56

10.

Hamilton

. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50–55. doi:10.1111/j.2044-8341.1959.tb00467.x

11.

Arıkan

Günver

İlhan

. Gamma oscillations predict paroxetine response of patients with obsessive compulsive disorder. J Obsessive Compuls Relat Disord. 2021;28(3):100620. doi:10.1016/j.jocrd.2020.100620

12.

Simeon

Stein

Gross

Islam

Schmeidler

Hollander

. A double-blind trial of fluoxetine in pathologic skin picking. J Clin Psychiatry. 1997;58(8):341–347. doi:10.4088/JCP.v58n0802

13.

Bloch

Elliott

Thompson

Koran

. Fluoxetine in pathologic skin-picking: open-label and double-blind results. Psychosomatics. 2001;42(4):314–319. doi:10.1176/appi.psy.42.4.314

14.

Arbabi

Farnia

Balighi

, et al. Efficacy of citalopram in treatment of pathological skin picking, a randomized double blind placebo controlled trial. Acta Med Iran. 2008;46(5):367–372. Accessed September 22, 2021. https://acta.tums.ac.ir/index.php/acta/article/view/3500

15.

Keuthen

Jameson

Loh

Deckersbach

Wilhelm

Dougherty

. Open-label escitalopram treatment for pathological skin picking. Int Clin Psychopharmacol. 2007;22(5):268–274. doi:10.1097/YIC.0b013e32809913b6

16.

Arnold

Mutasim

Dwight

Lamerson

Morris

McElroy

. An open clinical trial of fluvoxamine treatment of psychogenic excoriation. J Clin Psychopharmacol. 1999;19(1):15–18. doi:10.1097/00004714-199902000-00005

17.

Kalivas

. Sertraline in the treatment of neurotic excoriations and related disorders. Arch Dermatol. 1996;132(5):589. doi:10.1001/archderm.1996.03890290131022

18.

Biondi

Arcangeli

Petrucci

. Paroxetine in a case of psychogenic pruritus and neurotic excoriations. Psychother Psychosom. 2000;69(3):165–166. doi:10.1159/000012386

19.

Ravindran

Lapierre

Anisman

. Obsessive-compulsive spectrum disorders: effective treatment with paroxetine. Can J Psychiatry. 1999;44(8):805–807. doi:10.1177/070674379904400808

20.

Hansen

Prichep

Bolwig

John

. Quantitative electroencephalography in OCD patients treated with paroxetine. Clinical Electroencephalography. 2003;34(2):70–74. doi:10.1177/155005940303400205

21.

Prichep

Mas

Hollander

, et al. Quantitative electroencephalographic subtyping of obsessive-compulsive disorder. Psychiatry Research: Neuroimaging. 1993;50(1):25–32. doi:10.1016/0925-4927(93)90021-9

22.

Bolwig

Hansen

Merkin

Prichep

. Toward a better understanding of the pathophysiology of OCD SSRI responders: QEEG source localization. Acta Psychiatr Scand. 2007;115(3):237–242. doi:10.1111/j.1600-0447.2006.00889.x